Deerfield Management’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,255	Closed	-$153K	–	263
2024 Q3	$153K	Buy	13,255 +2,414	+22%	+$30.4K	﹤0.01%	430
2024 Q2	$128K	Sell	10,841 -4,512	-29%	-$52.7K	﹤0.01%	421
2024 Q1	$182K	Buy	+15,353	New	+$205K	﹤0.01%	340
2022 Q2	–	Sell	-830,472	Closed	-$12.2M	–	132
2022 Q1	$12.2M	Sell	830,472 -344,659	-29%	-$4.95M	0.27%	65
2021 Q4	$15.5M	Sell	1,175,131 -988,423	-46%	-$15.7M	0.33%	69
2021 Q3	$37.8M	Hold	2,163,554	–	–	0.74%	40
2021 Q2	$51.8M	Buy	2,163,554 +1,143,549	+112%	+$29.9M	0.92%	33
2021 Q1	$26.2M	Buy	+1,020,005	New	+$26.8M	0.55%	62
2019 Q4	–	Sell	-890,668	Closed	-$10.3M	–	89
2019 Q3	$10.3M	Sell	890,668 -327,000	-27%	-$5.28M	0.42%	59
2019 Q2	$27M	Buy	1,217,668 +567,668	+87%	+$13.3M	0.97%	35
2019 Q1	$18.6M	Hold	650,000	–	–	0.71%	44
2018 Q4	$12.8M	Hold	650,000	–	–	0.52%	54
2018 Q3	$14.4M	Buy	+650,000	New	+$8.79M	0.52%	60